DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 10 · Volume 86 · 2001 DOI: 10.1055/s-008-36011

Commentary

  • 939
    Simmonds, R. E.; Lane, D. A.:

    The Endothelial Cell Protein C Receptor: A Candidate Genetic Risk Factor for Thrombosis

  • 942
    Ewenstein, Bruce M.:

    Continuous Infusion of Recombinant Factor VIIa: Continue or not?

    • In Focus

  • 945
    Biguzzi, Eugenia; Merati, Giuliana; Liaw, Patricia C. Y.; Bucciarelli, Paolo; Oganesyan, Natalia; Qu, Dongfeng; Gu, Jian-Ming; Fetiveau, Raffaela; Esmon, Charles T.; Mannucci, Pier Mannuccio; Faioni, Elena M.:

    A 23bp Insertion in the Endothelial Protein C Receptor (EPCR) Gene Impairs EPCR Function

  • 949
    Smith, Mark P.; Ludlam, Christopher A.; Collins, Peter W.; Hay, Charles R. M.; Wilde, Jonathan T.; Grigeri, Alessandro; Melsen, Tina; Savidge, Geoffrey F.:

    Elective Surgery on Factor VIII Inhibitor Patients Using Continuous Infusion of Recombinant Activated Factor VII

  • 954
    Santagostino, E.; Morfini, M.; Rocino, A.; Baudo, F.; Scaraggi, F. A.; Gringeri, A.:

    Relationship between Factor VII Activity and Clinical Efficacy of Recombinant Factor VIIa Given by Continuous Infusion to Patients with Factor VIII Inhibitors

    • Review Article

  • 959
    Bajaj, Madhu S.; Birktoft, Jens J.; Steer, Sarah A.; Bajaj, S. Paul:

    Structure and Biology of Tissue Factor Pathway Inhibitor

    • Special Article

  • 973
    Gaetano, Giovanni de:

    A New Blood Corpuscle

  • 980
    Couturaud, Francis; Julian, Jim A.; Kearon, Clive:

    Low Molecular Weight Heparin Administered once versus twice Daily in Patients with Venous Thromboembolism

  • 985
    Constans, J.; Nelzy, M. L.; Salmi, L. R.; Skopinski, S.; Saby, J. C.; Le Métayer, P.; Morlat, P.; Conri, C.:

    Clinical Prediction of Lower Limb Deep Vein Thrombosis in Symptomatic Hospitalized Patients

  • 991
    Salvioni, Alessandro; Casilli, Francesco; Assanelli, Emilio; Grazi, Marco; Marenzi, Giancarlo; Guazzi, Maurizio D.:

    Comparison of Enoxaparin and Unfractionated Heparin on Thrombin Generation in Acute Coronary Syndromes without ST-Segment Elevation

  • 995
    Yanai, Hidekatsu; Chiba, Hitoshi; Fujiwara, Hironobu; Morimoto, Mie; Takahashi, Yukihiro; Hui, Shu-Ping; Fuda, Hirotoshi; Akita, Harukuni; Kurosawa, Takao; Kobayashi, Kunihiko; Matsuno, Kazuhiko:

    Metabolic Changes in Human CD36 Deficiency Displayed by Glucose Loading

  • 1000
    Couture, Patrick; Bovill, Edwin G.; Demers, Christine; Delage, Robert; Scott, Bruce T.; Valliere, Julia E.; Callas, Peter W.; Jomphe, Michèle; Rosendaal, Frits R.; Aiach, Martine; Long, George L.:

    Evidence of a Founder Effect for the Protein C Gene 3363 Inserted C Mutation in Thrombophilic Pedigrees of French Origin

  • 1007
    Kuhle, Stefan; Lane, David A.; Jochmanns, Kristin; Male, Christoph; Quehenberger, Peter; Lechner, Klaus; Pabinger, Ingrid:

    Homozygous Antithrombin Deficiency Type II (99 Leu to Phe Mutation) and Childhood Thromboembolism

  • 1012
    Kries, Rüdiger von; Junker, Ralf; Oberle, Doris; Kosch, Andrea; Nowak-Göttl, Ulrike:

    Foetal Growth Restriction in Children with Prothrombotic Risk Factors

  • 1017
    Simioni, Paolo; Kalafatis, Michael; Tormene, Daniela; Luni, Sonia; Zerbinati, Patrizia; Barzon, Luisa; Palù, Giorgio; Girolami, Antonio:

    Abnormal Propeptide Processing Resulting in the Presence of Two Abnormal Species of Protein C in Plasma

  • 1023
    Fitches, Alison C.; Lewandowski, Krzysztof; Olds, Robin J.:

    Creation of an Additional Glycosylation Site as a Mechanism for Type I Antithrombin Deficiency

  • 1028
    Mutch, N. J.; Robbie, L. A.; Booth, N. A.:

    Human Thrombi Contain an Abundance of Active Thrombin

  • 1035
    Mosnier, Laurent O.; Lisman, Ton; Berg, Marijke van den H.; Nieuwenhuis, Karel H.; Meijers, Joost C.M.; Bouma, Bonno N.:

    The Defective Down Regulation of Fibrinolysis in Haemophilia A Can Be Restored by Increasing the TAFI Plasma Concentration

  • 1040
    Mosnier, Laurent O.; Meijers, Joost C. M.; Bouma, Bonno N.:

    The Role of Protein S in the Activation of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) and Regulation of Fibrinolysis

  • 1047
    JirouȈsková, Markéta; Smyth, Susan S.; Kudryk, Bohdan; Coller, Barry S.:

    A Hamster Antibody to the Mouse Fibrinogen Chain Inhibits Platelet-fibrinogen Interactions and FXIIIa-mediated Fibrin Cross-linking, and Facilitates Thrombolysis

  • 1057
    Mosnier, Laurent O.; Elisen, Marc G.L.M.; Bouma, Bonno N.; Meijers, Joost C.M.:

    Protein C Inhibitor Regulates the Thrombin-Thrombomodulin Complex in the Up- and Down Regulation of TAFI Activation

  • 1065
    Dicker, Ira B.; Pedicord, Donna L.; Seiffert, Dietmar A.; Jamieson, G.A.; Greco, Nicholas J.:

    Both the High Affinity Thrombin Receptor (GPIb-IX-V) and GPIIb/IIIa Are Implicated in Expression of Thrombin-induced Platelet Procoagulant Activity

  • 1070
    Arvieux, J.; Regnault, V.; Hachulla, E.; Darnige, L.; Berthou, F.; Youinou, P.:

    Oxidation of β2-glycoprotein I (β2GPI) by the Hydroxyl Radical Alters Phospholipid Binding and Modulates Recognition by anti- β2GPI Autoantibodies

  • 1077
    Wang, Wen-Jeng; Huang, Tur-Fu:

    A Novel Tetrameric Venom Protein, Agglucetin from Agkistrodon acutus , Acts as a Glycoprotein Ib Agonist

  • 1087
    Topaz, On; Minisi, Anthony J.; Bernardo, Nelson L.; McPherson, Richard A.; Martin, Erika; Carr, Sheryl L.; Carr, Marcus E.:

    Alterations of Platelet Aggregation Kinetics with Ultraviolet Laser Emission: The “Stunned Platelet” Phenomenon

  • 1094
    Huang, Y-Q.; Li, J-J.; Hu, L.; Lee, M.; Karpatkin, S.:

    Thrombin Induces Increased Expression and Secretion of VEGF from Human FS4 Fibroblasts, DU145 Prostate Cells and CHRF Megakaryocytes

  • 1099
    Serradell, Mireia; Díaz-Ricart, Maribel; Cases, Aleix; Zurbano, María J.; Aznar-Salatti, José; López-Pedret, José; Ordinas, Antonio; Escolar, Ginés:

    Uremic Medium Disturbs the Hemostatic Balance of Cultured Human Endothelial Cells

  • 1106
    Dekker, Els den; Gorter, Gertie; Vuurst, Hans van der; Heemskerk, Johan W. M.; Akkerman, Jan-Willem N.:

    Biogenesis of G-protein Mediated Calcium Signaling in Human Megakaryocytes

    • Letters to the Editor

  • 1114
    Agostoni, Angelo:

    Ch. A. Owen “A History of Blood Coagulation”

  • 1115
    Matsuo, Takefumi; Matsuo, Miyako; Ouga-Maruyama, Satoko:

    Can Nafamostat Mesilate Be Used for Temporary Management of Hemodialysis in a Patient with Heparin-induced Thrombocytopenia (HIT)?

  • 1117
    Warner, Darren; Mansfield, Michael; Grant, Peter J.:

    Coagulation Factor XIII Levels in UK Asian Subjects with Type 2 Diabetes mellitus and Coronary Artery Disease

  • 1118
    Patscheke, Jochen H.; Arndt, Joachim; Dietz, Klaus; Zenner, Hans P.; Reuner, Karl H.:

    The Prothrombin G20210A Mutation Is a Risk Factor for Sudden Hearing Loss in Young Patients

  • 1119
    Sallah, Sabah; Wan, Jim Y.:

    Inhibitors against Factor VIII Associated with the Use of Interferon-alpha and Fludarabine

  • 1121
    Violi, Francesco; Micheletta, Fausta; Iuliano, Luigi:

    Clinical Trials with Vitamin E in Cardiovascular Disease: Are they Meaningful?

  • 1122
    Lindqvist, Pelle G.; Zöller, Bengt; Dahlbäck, Björn:

    Improved Hemoglobin Status and Reduced Menstrual Blood Loss among Female Carriers of Factor V Leiden – An Evolutionary Advantage?

  • 1123
    Fontaine, Magali; Homburger, Henry A.; Nichols, William L.:

    Persistent Problems with Standardization of Immunoassays for Anti-Cardiolipin Antibodies

  • 1125
    Kositchaiwat, Chomsri; Chuansumrit, Ampaiwan:

    Experiences with Recombinant Factor VIIa for the Prevention of Bleeding in Patients with Chronic Liver Disease Undergoing Percutaneous Liver Biopsies and Endoscopic Retrograde Cholangiopancreatography (ERCP)

  • 1126
    Saxon, Ben R.; Shanks, Deborah; Jory, Bryony C.; Williams, Vaughan:

    Effective Prophylaxis with Daily Recombinant Factor VIIa (rFVIIa-Novoseven) in a Child with High Titre Inhibitors and a Target Joint

  • 1127
    Arkel, Yale S.; Ku, De-Hui W.; Le, Phuong; Marie Carr, Ann:

    Comparison of a Test for Soluble Fibrin Polymer (TpPTM) with a Standard Quantitative ELISA for D-dimer in Patients, without Current Thrombosis, who Have Cancer or Renal Disease

  • 1129
    Horne, McDonald K.:

    Secondary Prophylaxis with Low Molecular Weight Heparin: The Dose?

  • 1130
    Song, Kyung S.; Choi, Jong R.; Kim, Hyun K.; Gee, Sun H.; Shim, Won H.:

    Presence of 844ins68 in the Cystathionine β-Synthase Gene in Asians (Koreans)

  • 1131
    Ghosh, K.; Shetty, S.; Mohanty, D.:

    Congenital Deficiency of Vitamin K Dependent Coagulation Factors – Its Rarity and Need for an International Registry

  • 1132
    Rosén, Steffen:

    A Rebuttal: Issues with the Assay of Factor VIII Activity in Plasma and Factor VIII Concentrates

  • 1133
    Lundblad, R.:

    Reply to a Rebuttal: Issues with the Assay of Factor VIII Activity in Plasma and Factor VIII Concentrates

  • 1133
    Bouchard, Beth A.; Silveira, Jay R.; Tracy, Paula B.:

    On the Role of EPR-1 or an EPR-1-like Molecule in Regulating Factor Xa Incorporation into Platelet Prothrombinase

  • 1135
    Briedé, Jacob J.; Heemskerk, Johan W.M.; van’t Veer, Cornelis; Hemker, Coenraad H.; Lindhout, Theo:

    Reply to Rebuttal: On the Role of EPR-1 or an EPR-1-like Molecule in Regulating Factor Xa Incorporation into Platelet Prothrombinase